Dr. Babu serves as an Associate Professor of Neurology at Harvard Medical School and is the Co-Director of the Neurological Research Institute at Massachusetts General Brigham. 

Suma's research is all centered around improving outcomes for people with ALS and is passionate about therapeutic development for ALS. She has a special interest in early phase clinical trials and gene targeted trials in ALS. Her studies are funded by the NIH, PCORI, Industry or Foundations. Dr. Babu is the PI of Healey ALS MyMatch Program, launched in 2025, which is a series of patient-centric, multi-site, Phase 1b/2a biomarker-driven clinical trials. She leads the neuroimaging research program for ALS at Mass General Hospital and co-chairs the NEALS neuroimaging subcommittee.